7DS-91738-18066 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-30
Registered in v-safe
2020-12-30
Dose 1 — Moderna
2020-12-30
Survey response — day 0, dose 1
MedDRA: Vision blurred — Feeling: Poor · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work

Free text: Blurry vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-30
Report sent to call center — day 0, dose 1
Be unable to work

1 call case(s)
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness, Nausea, Abdominal pain

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain

Adult check-in
2021-01-04
Call 1 — Left Voicemail
2021-01-07
Call 2 — Left Voicemail
2021-01-12
Call 3 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-30	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2020-12-30	Unsuccessful

Free text

Release 1 — day 0, dose 1

2020-12-30

Systemic reaction (other): Blurry vision

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release